CanSino Biologics Inc (CJH) — Financial Flexibility Index
CanSino Biologics Inc (CJH) has a Financial Flexibility Index of -0.07x as of June 2023. Free cash flow of €-288.61 Million (operating CF €-392.00 Million minus capex €103.39 Million) represents 0% of total liabilities (€3.93 Billion). Check CJH strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CanSino Biologics Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for CanSino Biologics Inc across 10 annual periods. See CJH working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for CanSino Biologics Inc (2016–2025)
Year-by-year free cash flow to debt coverage for CanSino Biologics Inc. For the full company profile including market capitalisation, see CanSino Biologics Inc (CJH) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | €321.76 Million | €77.86 Million | €2.22 Billion | ▲ +52.7% |
| 2024 | 0.09x | €288.85 Million | €-168.79 Million | €3.05 Billion | ▲ +248.9% |
| 2023 | -0.06x | €-256.59 Million | €-916.25 Million | €4.03 Billion | ▲ +65.4% |
| 2022 | -0.18x | €-776.53 Million | €-1.85 Billion | €4.22 Billion | ▼ -118.8% |
| 2021 | 0.98x | €3.25 Billion | €2.05 Billion | €3.33 Billion | ▲ +1174.5% |
| 2020 | -0.09x | €-61.64 Million | €-349.93 Million | €677.22 Million | ▲ +23.4% |
| 2019 | -0.12x | €-37.32 Million | €-154.25 Million | €313.98 Million | ▼ -235.3% |
| 2018 | 0.09x | €25.79 Million | €-123.64 Million | €293.56 Million | ▼ -79.0% |
| 2017 | 0.42x | €108.17 Million | €-56.30 Million | €259.03 Million | ▼ -49.1% |
| 2016 | 0.82x | €91.70 Million | €-34.38 Million | €111.70 Million | — |